IP Library Granted Patent US 7,723,470
Granted Patent B2
US 7,723,470 · App. 11/977,377 · Granted May 25, 2010

Glycopeptide derivatives and pharmaceutical compositions containing the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,723,470
App. No.
11/977,377
Granted
May 25, 2010
Kind
B2
Abstract

Disclosed are compounds of the formula: or a trifluoroacetic acid salt thereof, wherein A, B and Fmoc are as defined herein. Such compounds are useful as synthetic intermediates for preparing glycopeptides antibiotics.

Claims (15)

1. A compound of the formula:

wherein

A is —CH 2 — or —CH 2 CH 2 —;

B is n-heptyl, n-octyl, n-nonyl, n-decyl or n-undecyl; and

Fmoc is 9-fluorenylmethoxycarbonyl;

or a trifluoroacetic acid salt thereof.

2. The compound of claim 1 , wherein A is —CH 2 —.

3. The compound of claim 1 , wherein A is —CH 2 CH 2 —.

4. The compound of claim 1 , wherein B is n-heptyl.

5. The compound of claim 1 , wherein B is n-octyl.

6. The compound of claim 1 , wherein B is n-decyl.

7. The compound of claim 1 , wherein B is n-undecyl.

8. A compound of the formula:

or a trifluoroacetic acid salt thereof.

9. The compound of claim 1 , wherein B is n-nonyl.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033163/0031 →